Michelle Kirlew is outside of the typical demographics for pancreatic cancer patients. Unfortunately, she’s decades younger than the average patient, but fortunately she’s not in the seventy-four percent that die within one year of diagnosis. Michelle’s progress towards remission is measured by the results of medical tests and imaging… delivered to her by oncologist Emad Elquza.
By submitting your comments, you hereby give AZPM the right to post your comments and potentially use them in any other form of media operated by this institution.